TNF and inflammatory bowel disease: Due to a number of studies that have shown a link between increased TNFα levels and pathogenesis of IBD [37,38,39], as well as the therapeutic potential of anti-TNFα therapy and soluble TNFα receptors [40], we sought to investigate the role of macrophage-secreted TNFα and OJS administration in colitis.